
The single most actionable fact for Asian equity investors in mid-2026 is that small tariff differentials are now steering enormous sourcing decisions. After the Supreme Court struck down the earlier reciprocal tariffs, a flat 10% Section 122 surcharge took effect in February 2026, collapsing Vietnam's headline rate from 46% and India's from a higher reciprocal band to a common 10% baseline 2. That truce expires around July 24, and what replaces it is bilateral and uneven. Vietnam has settled at roughly 20% on direct exports; India is racing to lock in 18% before the deadline 1 3. As one analysis put it, a two-dollar gap on a $100 shirt can meaningfully shift purchasing decisions for importers buying millions of units 3. For portfolios, this means the old habit of treating 'Asia ex-China' as one trade is obsolete. Country selection, and even factory-level origin compliance, is now the alpha.
The emerging hierarchy is becoming legible. India is negotiating an 18% ceiling, explicitly to undercut rivals whose rates exceed 20%, and its exposed sectors are large: textiles near $15.5 billion, pharmaceuticals around $12.7 billion, and gems and jewellery near $10 billion of annual US-bound trade 3. Vietnam sits at about 20% on genuine local production, with Indonesia around 19% and other ASEAN deals with Thailand, Malaysia, the Philippines, and Cambodia clustering in the 19-20% range 1. China remains the outlier: on top of the 10% baseline it still carries Section 301 duties of 25-100%, pushing effective rates to roughly 35% on electronics, 60% on solar panels, and 110% on electric vehicles 2. The looming risk is that the July truce gives way to a proposed 12.5% Section 301 layer across dozens of economies, including Vietnam, India, Thailand, Japan, and Korea, which has no statutory rate cap or time limit 2. Investors should treat the current rates as a floor, not a settled equilibrium.
The most underpriced risk is the 40% transshipment penalty embedded in the Vietnam framework, double the 20% direct-export rate and widely read as aimed at Chinese goods routed through third countries 1. The problem is enforcement ambiguity. Finished products assembled in Vietnam using a high share of Chinese components can legally claim Vietnamese origin under existing RCEP rules, so distinguishing genuine manufacturing from minimal repackaging is genuinely hard 1. Because regional frameworks like RCEP and the upgraded China-ASEAN agreement were built to facilitate cross-border production, tightening US rules of origin cuts against the grain of how Asian supply chains actually operate 1. If a similar 40% clause propagates to other ASEAN deals, exporters with thin domestic value-add face sudden margin cliffs. The practical takeaway: companies that have invested in deep local content, traceable bills of materials, and audit-ready documentation will command a compliance premium, while asset-light assemblers dependent on Chinese inputs carry latent tariff risk that may not yet be in their valuations.
The rerouting is not hypothetical. ASEAN goods exports to the United States ran roughly 23% above prior-year levels in late 2025, with Vietnam and Thailand leading at around 30% growth 4. Vietnam's exports to the US rose 28.1% in 2025 to more than $153 billion, and its computers and electronics shipments crossed $100 billion for the first time, with the US importing $22.5 billion of that category in just the first five months of 2026 5. Foreign-invested manufacturing is expanding fast, evidenced by a 45% surge in FDI-sector imports of inputs 5. The clear winners are electronics and machinery assemblers in Vietnam, India's textile and pharma exporters if the 18% deal lands, and Thailand's EV-adjacent supply base. The losers are Chinese direct exporters facing compound duties, and any Asian firm whose value proposition was pure tariff arbitrage rather than real capability. China's exports to the US fell roughly 20% in 2025 even as its total exports grew, confirming trade is being redirected rather than destroyed 4.
For investors, three moves follow. First, favour exporters with demonstrable local content and origin compliance over pure passthrough assemblers, because the 40% transshipment penalty is a tail risk that will separate quality names from arbitrage plays 1. Second, treat the July 24 expiry and the July 20 Section 301 investigation deadlines as binary catalysts: an Indian 18% deal would be a relative-value tailwind for Mumbai-listed textile and pharma exporters versus Vietnamese peers, while a broad 12.5% Section 301 overlay would compress the entire region's margins 2 3. Third, pair export-oriented positions with domestic-demand exposure in India and Indonesia to hedge against the possibility that the tariff wall keeps rising. The multi-year structural story, China-plus-one relocation into Vietnam, India, and Thailand, remains intact and is arguably accelerating 4 5. But 2026 is the year the trade splinters by country, by sector, and by compliance posture, and undifferentiated Asian-exporter exposure now carries risks that granular selection can avoid.





View certificate